Bovine Hemoglobin-Based Oxygen Carrier Treatment in a Severely Anemic Jehovah’s Witness Patient After Cystoprostatectomy and Nephrectomy

2019 ◽  
Vol 12 (7) ◽  
pp. 243-245 ◽  
Author(s):  
Ian Brotman ◽  
Matthew Kocher ◽  
Stephen McHugh
2012 ◽  
Vol 26 (3) ◽  
pp. 257-260 ◽  
Author(s):  
Shane D. Jordan ◽  
Earnest Alexander

Introduction: Management of severe symptomatic anemia in critically ill Jehovah’s Witness patients remains a challenge. The paucity of therapeutic alternatives to human red blood cells has prompted the use of blood substitutes. Case Report: A 19-year-old female Jehovah’s Witness patient presented to the emergency department following several episodes of syncope. She was found to have a positive Coombs test and was diagnosed with warm-bodied autoimmune hemolytic anemia. Upon admission, her hemoglobin was 8.4 g/dL, then dropped to a nadir of 2.8 g/dL 4 days later. She received traditional management with corticosteroids, intravenous immune globulin, rituximab, and partial splenic artery embolization. Despite these therapies, hemoglobin levels failed to respond, and she experienced signs of marked ischemia. A decision was made to give 2 units of Hemopure, a bovine hemoglobin-based oxygen carrier, and the hemoglobin levels increased to 8.7 g/dL 10 days later. The patient’s overall clinical condition improved leading to subsequent hospital discharge. Conclusion: This case exemplifies the ingenuity that health care practitioners must use in critical situations involving the medical management of anemic Jehovah’s Witness patients who refuse blood products. Hemopure was used as “bridging treatment” to help save a patient from the devastating effects of ischemia resulting from severe anemia.


2007 ◽  
Vol 55 (6) ◽  
pp. 262-265 ◽  
Author(s):  
Takayuki Kadohama ◽  
Nobuyuki Akasaka ◽  
Tadahiro Sasajima ◽  
Kazutomo Goh ◽  
Nobuyoshi Azuma ◽  
...  

2017 ◽  
pp. 341-351
Author(s):  
Chantal Lerminiaux ◽  
Philippe Van der Linden

2007 ◽  
Vol 64 (4) ◽  
pp. 212-219 ◽  
Author(s):  
Nimesh P. Nagarsheth ◽  
Aryeh Shander ◽  
Robert Malovany ◽  
Jausheng Tzeng ◽  
Ibrahim Ibrahim

2018 ◽  
pp. bcr-2018-226486
Author(s):  
Sayaka Tachi ◽  
Noriko Yoneda ◽  
Satoshi Yoneda ◽  
Shigeru Saito

A 35-year-old Jehovah’s Witness patient with total placenta previa was referred to our hospital at 30 weeks of gestation. She refused autologous and allogeneic blood transfusions, but agreed to receive acute normovolaemic haemodilution, intraoperative blood salvage and biological products. At 35 weeks, she underwent emergent caesarean delivery because of labour pains. Multidisciplinary therapy, including the insertion of balloon catheters into the bilateral common iliac arteries, acute normovolaemic haemodilution and intraoperative blood salvage, avoided hysterectomy; however, blood loss included amniotic fluid which was estimated to be 1910 mL. These treatments may be effective for total placenta previa in blood-refusal patients.


Author(s):  
José Ramón Díez Rodríguez

El paciente testigo de Jehová y su rechazo a determinados tratamientos médicos, en concreto a las transfusiones de sangre, constituye uno de los problemas fundamentales con el que históricamente se ha tenido que enfrentar el derecho sanitario. La actual Ley 41/2002 de autonomía del paciente parece dejar claro el supuesto del paciente mayor de edad y la posibilidad de rechazar tratamientos médicos, pero mayores problemas plantean los supuestos del menor de edad, y especialmente la figura del menor maduro, y el supuesto de la mujer embarazada testigo de Jehová. Será necesario atender a la proporcionalidad de derechos en conflicto para determinar los criterios que en cada caso nos permitan inclinar la balanza a favor de una u otra posición.The Jehovah’s Witness patient and their rejection of certain medical treatments, namely blood transfusions, is one of the fundamental problems with which historically had to face the health law. The current Law 41/2002 of patient autonomy seems to clarify the adult patient’s adult and their possibility of refusing medical treatment, but major problems posed minor assumptions, especially the mature minor figure, and the course pregnant woman Jehovah’s Witness. It will be necessary to address the proportionality of conflicting rights, and determining criteria in each case allow us to tip the balance in favor of one position or another.


2002 ◽  
Vol 36 (4) ◽  
pp. 729-730 ◽  
Author(s):  
Ted Walton ◽  
Edwin J Macon

Perfusion ◽  
2021 ◽  
pp. 026765912110477
Author(s):  
Abrahán Mera ◽  
Eduard Argudo ◽  
María Martínez-Martínez ◽  
Clara Palmada ◽  
Camilo Bonilla ◽  
...  

Extracorporeal Membrane Oxygenation (ECMO) is commonly associated with a high blood transfusion requirement. Jehovah’s Witness patients present a particular challenge. The impossibility of transfusing blood cells and starting anticoagulation treatment are common contraindications for this supportive measure. Here we report the case of a Jehovah’s Witness patient with refractory hypoxemia due to influenza A H1N1 pneumonia who required venovenous ECMO for 11 days. We describe the use of a bloodless approach to reduce the waste of blood, avoiding anticoagulation, and improving red blood cell production. We then summarize the current literature on the use of ECMO in Jehovah’s Witness patients and, finally, we propose some recommendations for their management.


Sign in / Sign up

Export Citation Format

Share Document